Article

Symposium tackles difficult issues of glaucoma

Cardiovascular medicine has provided a road map that ophthalmology can follow in risk assessment.

The program was jointly sponsored by The New York Eye and Ear Infirmary and Ophthalmology Times and supported through an unrestricted educational grant from Alcon Laboratories Inc.

Robert N. Weinreb, MD, director, Hamilton Glaucoma Center, and distinguished professor of ophthalmology at the University of California, San Diego, served as program chairman and moderator for the event.

Assessing risk Cardiovascular medicine has provided a road map that ophthalmology can follow in risk assessment, said Dr. Fechtner, professor of ophthalmology and director, glaucoma division, at the New Jersey Medical School, University of Medicine and Dentistry of New Jersey in Newark.

Cardiologists conducted studies that looked at the risk of a cardiac event based on cholesterol and age, a process similar to assessing the risk of glaucoma by IOP and age, Dr. Fechtner said.

And, in both cardiology and ophthalmology, risk factors have been identified through several large clinical trials, although in the cause of glaucoma, the risks may be different for progression from ocular hypertension to glaucoma from those for progression from glaucoma to more advanced disease, Dr. Fechtner said.

"But a lot of the same risk factors are starting to fall out, and we are beginning to be able to assign values to them," he said.

"In glaucoma we're getting close," Dr. Fechtner said.

"I don't know what the risk factors are going to be or how they'll be weighted, and I don't know how they'll be distributed across age groups.

"But I can tell you that the data sets exist and they're being examined. I would predict we're going to have our first risk calculators available within the next few years," he continued.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.